| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/07/2001 | WO2001039756A1 Patch therapeutic agent delivery device having texturized backing |
| 06/07/2001 | WO2001039755A1 Therapeutic agent delivery device incorporating reflective optical film |
| 06/07/2001 | WO2001039754A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | WO2001039753A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 06/07/2001 | WO2001039752A2 Transdermal therapeutic system containing highly volatile active ingredients |
| 06/07/2001 | WO2001039751A1 Injection molding method for (meth)acrylate copolymers having tertiary ammonium groups |
| 06/07/2001 | WO2001039750A1 Effervescent histamine h2 antagonist composition |
| 06/07/2001 | WO2001039749A2 Fast dissolving composition with prolonged sweet taste |
| 06/07/2001 | WO2001039748A2 Orally administrable pharmaceutical product and method of fabrication therefor |
| 06/07/2001 | WO2001039747A2 Cassette-shaped constructional units in a rotary printing machine |
| 06/07/2001 | WO2001039746A1 Pharmaceutical superdisintegrant |
| 06/07/2001 | WO2001039745A2 Aerosol composition comprising formoterol |
| 06/07/2001 | WO2001039744A2 Radiation sensitive liposomes |
| 06/07/2001 | WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 06/07/2001 | WO2001039741A2 Mitomycin c solution |
| 06/07/2001 | WO2001039725A2 Drug preparations |
| 06/07/2001 | WO2001039608A1 Addition of tetracyclines to animal foodstuffs |
| 06/07/2001 | WO2001039606A1 Chewing gum compositions |
| 06/07/2001 | WO2001039601A1 Nutritional composition |
| 06/07/2001 | WO2001039582A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | WO2001025213A3 Pyrrolo imidazole derivatives and their use as medicaments |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001013780A3 Apparatus and method for anesthetizing the cervical region of a female |
| 06/07/2001 | WO2001008641A3 Personal care articles |
| 06/07/2001 | WO2001001964A3 Ionically formulated biomolecule microcarriers |
| 06/07/2001 | WO2000072823A8 Preparations for the application of anti-inflammatory agents |
| 06/07/2001 | WO1999002187A3 Decreased fat absorption with an anti-lipase antibody |
| 06/07/2001 | US20010003003 Preservative for emulsion and emulsion containing same |
| 06/07/2001 | US20010003001 Compounds and compositions for delivering active agents |
| 06/07/2001 | US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | US20010002993 For ultrasound imaging; injectable aqueous medium having gas dispersed therein and composition comprising a diffusible component capable of diffusion in vivo into said dispersed gas so as at least transiently to increase the size thereof |
| 06/07/2001 | DE19958472A1 Teilchenförmiges Kompositmaterial zur gesteuerten Freisetzung eines Wirkstoffs Particulate composite material for controlled release of an active substance |
| 06/07/2001 | DE19958007A1 Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen Injection molding process for (meth) acrylate copolymers with teritiären ammonium groups |
| 06/07/2001 | DE19957898A1 Treatment of legionnaire's disease using pulmonary surfactant preparation, preventing acute lung injury or adult respiratory distress syndrome without risk of development of resistance |
| 06/07/2001 | DE19957763A1 Vessel-like particles containing encapsulated cells, useful e.g. as substitute for feeder cells in animal cell cultures, provide material exchange with their surroundings |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2393233A1 Carbon dioxide enhancement of inhalation therapy |
| 06/07/2001 | CA2393231A1 Pharmaceutical superdisintegrant |
| 06/07/2001 | CA2392810A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| 06/07/2001 | CA2392402A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 06/07/2001 | CA2392184A1 Nutritional composition |
| 06/07/2001 | CA2392102A1 Use of a buffer to prevent candida albicans infections on the skin |
| 06/07/2001 | CA2392029A1 Comminuted form of (s)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid |
| 06/07/2001 | CA2391646A1 Solid preparation |
| 06/07/2001 | CA2390841A1 Drug preparations |
| 06/07/2001 | CA2390838A1 Patch therapeutic agent delivery device having texturized backing |
| 06/07/2001 | CA2388026A1 Targeted drug delivery with a cd44 receptor ligand |
| 06/07/2001 | CA2327369A1 Diluent and disintegrating composition, process for obtaining it and its use |
| 06/06/2001 | EP1104777A1 Gelatin and a process for producing the same |
| 06/06/2001 | EP1104767A1 Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| 06/06/2001 | EP1104683A1 Device for the injection of antiparasitic agents into pet animals |
| 06/06/2001 | EP1104673A1 A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition |
| 06/06/2001 | EP1104544A1 Method for controlling a coating process |
| 06/06/2001 | EP1104313A2 Methods, instruments and materials for chondrocyte cell transplantation |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104296A1 Bioimplant formulation |
| 06/06/2001 | EP1104291A1 Pellets having a core coated with an antifungal and a polymer |
| 06/06/2001 | EP1104290A1 Microemulsions as solid dosage forms for oral administration |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104288A1 Orally disintegrable tablet forming a viscous slurry |
| 06/06/2001 | EP1104287A2 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 06/06/2001 | EP1104286A1 Composite hydrogel drug delivery systems |
| 06/06/2001 | EP1104280A2 Topical delivery systems for active agents |
| 06/06/2001 | EP1104236A1 Transdermally delivered aspirin |
| 06/06/2001 | EP1104233A1 Improved film-forming compositions for protecting animal skin |
| 06/06/2001 | EP1005324A4 Compositions for delivery of biological agents and methods for the preparation thereof |
| 06/06/2001 | EP0883695B1 Method and composition for hair removal |
| 06/06/2001 | EP0881904B1 Topical pharmaceutical composition containing heparin |
| 06/06/2001 | EP0671176B1 Percutaneously absorbable preparation |
| 06/06/2001 | CN2432938Y Anti-inflammatory and analgesic adhesive plaster |
| 06/06/2001 | CN1298311A A drug composition containing sodium Pravastatin |
| 06/06/2001 | CN1298310A Stable mitoxantron solutions |
| 06/06/2001 | CN1298307A Enhancement of immunity by intranasal inoculation of IL-12 |
| 06/06/2001 | CN1298303A Stable compositions comprising levosimendan and alginic acid |
| 06/06/2001 | CN1298302A Topical administration of oxazolidinones for transdermal delivery |
| 06/06/2001 | CN1298298A Periadventitial delivery device |
| 06/06/2001 | CN1298297A Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 06/06/2001 | CN1298296A Erythropoietin Liposomal dispersion |
| 06/06/2001 | CN1298295A Method and compositions for stabilizing acetylcholine compositions |
| 06/06/2001 | CN1298294A Nicotine inhaler |
| 06/06/2001 | CN1297778A New drug form for human body cavity and its implementation |
| 06/06/2001 | CN1297769A Orthopaedic and traumatological plaster |
| 06/06/2001 | CN1297768A Medicated cigarette for treating pulmonary tuberculosis and its making process |
| 06/06/2001 | CN1297767A External-use burn ointment |
| 06/06/2001 | CN1297764A Fast-acting trauma remedy |
| 06/06/2001 | CN1297743A Buccal tablet of Qingqian Willow leaf |
| 06/06/2001 | CN1297737A Preparation of medicine for restoring the normal transmitting function of nerve |
| 06/06/2001 | CN1066627C Throat disease curing drop and its preparation |
| 06/06/2001 | CN1066624C Dry mix formulation for bisphosphonic acids |
| 06/06/2001 | CA2325106A1 Compositions and methods for intranasal delivery of active agents to the brain |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242590 Antisense modulation of zinc finger protein-217 expression |
| 06/05/2001 | US6242496 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242492 N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid in iron chelating therapy |
| 06/05/2001 | US6242472 Mixing with perfluorocarbon liquid carrier; medical diagnosis |
| 06/05/2001 | US6242441 Use of brinzolamide to prevent visual field loss |
| 06/05/2001 | US6242423 The pharmaceutical composition can be used for injection or for percutaneous or ocular application. |